AXGN — Axogen, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 805928 ·
Last close
$43.39
Market Cap
$2.33B
52W High
$52.91
52W Low
$15.27
ADV30
1,147,267
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 69,731,000 | 50,674,000 | -2,156,000 | -1,516,000 | 304,863,000 | 94,572,000 | 48,606,000 |
| Mar 2026 | 61,457,000 | 46,189,000 | -2,832,000 | -19,584,000 | 289,488,000 | 82,654,000 | 44,680,000 |
| Dec 2025 | 59,904,000 | 44,409,000 | -9,772,000 | -13,156,000 | 221,687,000 | 35,548,000 | 92,840,000 |
| Sep 2025 | 60,082,000 | 45,993,000 | 1,912,000 | 708,000 | 216,400,000 | 23,902,000 | 95,595,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$15,047,000
Investing CF
$-15,173,000
Financing CF
$70,662,000
CapEx
$-8,537,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.68
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-328,063,000
Inventory
$47,313,000
Receivables
$34,126,000
ST Investments
$16,840,000
EBIT TTM
$-29,378,000
Pretax Income TTM
$-33,548,000
Interest Exp TTM
$4,170,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$251,174,000
EBITDA
$-5,968,000
Free Cash Flow
$18,232,750
Enterprise Value
$2,175,239,424
Total Cash
$111,412,000
Total Debt
$20,066,000
Shares Out
53,761,513
Trailing EPS
$-0.67
Book Value
$4.78
ROE
-18.2%
ROA
-3.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 225,208,000 | -7,849,000 | -15,703,000 | 221,687,000 | 92,840,000 | 128,847,000 | 812,000 |
| Dec 2024 | 187,338,000 | -3,287,000 | -9,964,000 | 203,728,000 | 99,821,000 | 103,907,000 | 4,535,000 |
| Dec 2023 | 159,012,000 | -21,462,000 | -21,716,000 | 196,827,000 | 101,162,000 | 95,665,000 | -5,716,000 |
| Dec 2022 | 138,584,000 | -29,707,000 | -28,948,000 | 195,387,000 | 94,388,000 | 100,999,000 | -16,066,000 |
TTM Snapshot
Revenues TTM
$175,434,000
NetIncome TTM
$-14,099,000
OpCashFlow TTM
$0
Assets (Latest)
$221,687,000
Forward EPS
$0.69
Max Pain — expiry 2026-10-16
max pain strike: $45.00 · spot: $42.52 · call oi: 3,266 · put oi: 286
Expected Move to 2026-10-16:
±$6.18
(14.52%) —
implied range
$36.35 –
$48.70
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BFLY | Butterfly Network, Inc. | $2.30B | $9.39 | — |
| UFPT | UFP TECHNOLOGIES INC | $2.29B | $295.65 | — |
| INSP | Inspire Medical Systems, Inc. | $2.04B | $70.50 | — |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $1.97B | $65.97 | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.88B | $38.49 | — |
News headlines (Yahoo Finance, 1h cache)
2 Medical-Device Stocks Lighting Up the Options Pits
2026-09-10 14:47 · Yahoo
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
2026-09-10 10:01 · Yahoo
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
2026-09-01 11:00 · Yahoo
Axogen (AXGN) Q2 2026 Earnings Call Transcript
2026-08-08 01:28 · Yahoo
Axogen Inc (AXGN) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges
2026-07-29 19:03 · Yahoo
NZS Capital Added Axogen (AXGN) as an Optionality Position
2026-07-21 14:25 · Yahoo
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026
2026-07-15 11:00 · Yahoo
AxoGen, Stock Of The Day, Offers Entry After Bullish Rebound
2026-06-05 19:57 · Yahoo
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair
2026-09-10 16:31 · Yahoo
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
2026-09-10 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.